Barrow, Hanley, Mewhinney & Strauss’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-114,679
Closed -$224K 366
2020
Q1
$224K Sell
114,679
-65,515
-36% -$128K ﹤0.01% 268
2019
Q4
$748K Buy
+180,194
New +$748K ﹤0.01% 250